Универзитетски клинички центар Србије је један од здравствених центара који се налази на општини Савски венац у Београду, Србија. Састоји се из преко 30 клиника и центара који су специјализовани за психијатрију, кардиологију, ендокринологију, гинекологију, урологију и др.

During the past decade, Clinical Center of Serbia conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 57 clinical trials were completed, i.e. on average, 48.3% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 42 clinical trials were completed. i.e. 73.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Center of Serbia" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Clinical Centre of Serbia" with 11 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Pfizer" with 6 trials sponsored and "Boehringer Ingelheim" with 6 trials sponsored. Other sponsors include 122 different institutions and companies that sponsored additional 99 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Center of Serbia" #1 collaborator was "Clinical Centre of Serbia" with 4 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Medtronic" with 3 trials as a collaborator, "Military Medical Academy, Belgrade, Serbia" with 3 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include 110 different institutions and companies that were collaborators in the rest 117 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Center of Serbia" are "Coronary Artery Disease" (6 trials), "Crohn's Disease" (6 trials), "Multiple Sclerosis" (6 trials), "Depressive Disorder, Major" (5 trials) and "Acromegaly" (4 trials). Many other conditions were trialed in "Clinical Center of Serbia" in a lesser frequency.

Most popular intervention types in "Clinical Center of Serbia" are "Drug" (124 trials), "Device" (22 trials), "Biological" (11 trials), "Other" (11 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (58 trials), "Carboplatin" (6 trials), "Pemetrexed" (5 trials), "placebo" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Center of Serbia" are 165 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Center of Serbia". undefined are not yet recruiting, 29 are recruiting, 21 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 93 completed trials in Clinical Center of Serbia, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Center of Serbia, 4 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 17 trials that are defined as “Not Applicable".